Skip to content

Clinical application of tissue inducible biomaterials

Clinical application of tissue inducible biomaterials

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066275
Enrollment
Unknown
Registered
2022-11-30
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

Implantation of spinal nerve sheath group:N/A

Sponsors

Tsinghua University Yuquan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 53 Years

Inclusion criteria

Inclusion criteria: 1 Age: 18-60 2 Gender: male or female 3 Time after spinal cord injury>6 months 4 Thoracic spinal cord complete transverse injury (ASIA grade A or B) 5 No other neurological or psychological disorders 6 No obvious muscle atrophy, bedsore and other complications

Exclusion criteria

Exclusion criteria: 1 Refusing to sign the informed consent 2 Spinal cord injury caused by non traumatic reasons 3 Non thoracic spinal cord injury 4 Participated in other clinical trials within 90 days before the start of this study 5 Have received other stem cell therapy or applied immunosuppressant 6 Other neurological or psychological disorders 7. The physical condition is not suitable for moderate intensity rehabilitation training 8 Pregnant or lactating women 9 Those who have obvious muscle atrophy, joint deformation, bedsore and other complications

Design outcomes

Primary

MeasureTime frame
Laboratory tests (blood routine test, biochemistry, hemogram, autoimmune antibody, tumor marker);

Secondary

MeasureTime frame
MRI;CT;Urodynamic test;Pelvic floor electromyography;Pelvic floor electromyography;Electrophysiological electromyography;

Countries

China

Contacts

Public ContactZhiqiang Cui
1656957600@qq.com13522800037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026